Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Proteome Sciences plc    PRM   GB0003104196

Delayed Quote. Delayed  - 05/24 05:35:20 pm
17.25 GBp   -10.39%
05/18 PROTEOME SCIENC : Appoints New CEO As Annual Loss Narrows
04/05 PROTEOME SCIENC : Block Admission Report
04/05 PROTEOME SCIENC : Welcomes Supportive Reports On Protein Profiling
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
05/18/2016 05/19/2016 05/20/2016 05/23/2016 05/24/2016 Date
19.25(c) 19.125(c) 18.875(c) 19.25(c) 17.25(c) Last
212 753 12 129 128 747 35 552 232 337 Volume
-3.75% -0.65% -1.31% +1.99% -10.39% Change
More quotes
Financials ( GBP)
Sales 2016 3,00 M
EBIT 2016 -2,70 M
Net income 2016 -3,00 M
Debt 2016 9,40 M
Yield 2016 -
Sales 2017 -
EBIT 2017 -
Net income 2017 -
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017 -
Capi. / Sales 2016 16,2x
Capi. / Sales 2017 -
Capitalization 39,3 M
More Financials
Company
Proteome Sciences Plc engages in applied proteomics and peptidomics services and applications.It offers proprietary technologies for protein and peptide biomarker discovery, validation, and assay development.It focuses on developing proprietary protein biomarkers for neurological diseases,... 
More about the company
Latest news on PROTEOME SCIENCES PLC
05/18 PROTEOME SCIENCES : Appoints New CEO As Annual Loss Narrows
04/05 PROTEOME SCIENCES : Block Admission Report
04/05 PROTEOME SCIENCES : Welcomes Supportive Reports On Protein Profiling
04/05 PROTEOME SCIENCES : Deep Protein Profiling Key To Improving Cancer Treatment
02/29 PROTEOME SCIENCES : Starts 2016 Well, Production Capacity Up
02/29 PROTEOME SCIENCES : Trading Update
01/08 PROTEOME SCIENCES : Director Dealing
2015 PROTEOME SCIENCES : Gets Positive Results From CK1d Inhibitors Study
More news
Sector news : Bio Therapeutic Drugs
05/24DJGILEAD SCIENCES : Names New Operating Chief
05/24 GILEAD SCIENCES : Announces Appointment of Kevin Young CBE as Chief Operating Of..
05/24DJNant Health Seeks $82 Million in IPO
More sector news : Bio Therapeutic Drugs


Comments 
Advertisement
Chart PROTEOME SCIENCES PLC
Duration : Period :
Proteome Sciences plc Technical Analysis Chart | PRM | GB0003104196 | 4-Traders
Full-screen chart
Technical analysis trends PROTEOME SCIENCES...
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials